SBC Medical Group Holdings Inc
SBC- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001930313
No open-market purchases or sales by SBC Medical Group Holdings Inc insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $13.5M in total; no superinvestor holds it.
Other share classesSBCWW
13F holders, Q4 2023
Institutional positions in SBC Medical Group Holdings Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +2 vs. Q3 2023
- Shares held
- 1.86M
- +48.5K (+2.7%) vs. Q3 2023
- Total value
- $19.8M
- +$632.1K (+3.3%) vs. Q3 2023
- New holders
- 2
- 1 more added
- Sold out
- 0
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $13.5M |
| Q1 2026 | 50 | $6.07M |
| Q4 2025 | 42 | $5.69M |
| Q3 2025 | 42 | $3.68M |
| Q2 2025 | 29 | $2.96M |
| Q1 2025 | 4 | $288.0K |
| Q4 2024 | 4 | $173.0K |
| Q3 2024 | 3 | $27.9K |
| Q2 2024 | 5 | $1.90M |
| Q1 2024 | 5 | $2.67M |
| Q4 2023 | 15 | $19.8M |
| Q3 2023 | 13 | $19.1M |
| Q2 2023 | 13 | $18.8M |
| Q1 2023 | 38 | $106.4M |
| Q4 2022 | 45 | $102.7M |
| Q3 2022 | 21 | $55.4M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding SBC Medical Group Holdings Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Radcliffe Capital Management, L.P. | 299,896 | $3.22M | 0.43% | −1000.0% | Reduced |
| Crystalline Management Inc. | 291,000 | $3.12M | 3.96% | 00.0% | Unchanged |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 250,000 | $2.68M | 0.04% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 216,642 | $2.33M | 0.04% | −672−0.3% | Reduced |
| Saba Capital Management, L.P. | 200,000 | $2.15M | 0.05% | 00.0% | Unchanged |
| Verition Fund Management LLC | 182,682 | $1.95M | 0.02% | 00.0% | Unchanged |
| Walleye Capital LLC | 144,064 | $1.55M | 0.02% | 00.0% | Unchanged |
| Centiva Capital, LP | 97,000 | $1.04M | 0.06% | 00.0% | Unchanged |
| Walleye Trading LLC | 81,036 | $872.8K | 0.01% | 00.0% | Unchanged |
| Berkley W R Corp | 27,062 | $289.3K | 0.02% | +27,062 | New |
| K2 Principal Fund, L.P. | 21,089 | $225.0K | 0.05% | +21,089 | New |
| Tuttle Tactical Management | 28,738 | $155.2K | 1.08% | 00.0% | Unchanged |
| Deutsche Bank AG | 13,533 | $144.4K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 3,983 | $42.9K | 0.00% | +1,183+42.3% | Added |
| UBS Group AG | 1 | $11 | 0.00% | −57−98.3% | Reduced |